MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes

F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

Meeting: 2017 International Congress

Abstract Number: 498

Keywords: Chorea (also see specific diagnoses, Depression, etc): Clinical features, Huntingtons disease

Session Information

Date: Tuesday, June 6, 2017

Session Title: Huntington's Disease

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To better understand the relationship between Huntington’s Disease and depression.

Background: Huntington’s Disease (HD) is an uncommon genetic neurodegenerative disorder in the United States that is frequently characterized by significant psychiatric and behavioral comorbidities, including depression. Drawing from a large database of patients hospitalized with HD, the current study provides a preliminary comparison of patients with and without a comorbid diagnosis of depression in terms of key demographic, length of stay (LOS), cost and discharge disposition.

Methods: The National Inpatient Sample database was queried for the period of 2003-2013 for patients discharged with a diagnosis of HD, ICD-9 Code 333.4. HD patients with comorbid depression were identified using Agency of Healthcare Research and Quality (AHRQ) criteria. We compared age, LOS, total hospital charges between HD patients with and without depression, as well as association between depression and patient race, sex, and discharge/disposition status.

Results: From 2003-2013, a total of 159,329 HD patient discharges were identified. Analyses revealed that 18.8% of the sample met criteria for depression. Comorbid depression was associated with more advanced age (mean 56.45 years versus 55.14 years, p=0.002), female gender (20.3%versus 17.1%, p<0.001) decreased length of stay (6.36 days versus 8.05 days, p<0.001) and lower total cost of admission ($32,059 versus $37,159 p=0.011). However, HD with comorbid depression was associated with lower rates of being discharged home (28.2% versus 31.7%, p=0.001). Of HD patients with depression, 55.8% were discharged to a Skilled Nursing Facility (SNF) while only 49.8% of those without depression went to a SNF (p=0.001). [table1]

Conclusions: These results demonstrate that depression is a significant comorbidity in HD patients. Current findings point to race and gender disparities in HD patients diagnosed with depression. The presence of depression also correlated interestingly with decreased length of stay and lower cost to the patient, but with disposition to a higher acuity of care than patients without depression. While more rapidly discharged, these patients may have worse levels of function hence require higher levels of care. Further research is warranted to delineate the true impact of depression on HD patients.

To cite this abstract in AMA style:

F.S. Benesh, S. Gupta, V. Sung. Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/depression-among-inpatients-with-huntingtons-disease-patient-characteristics-and-outcomes/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/depression-among-inpatients-with-huntingtons-disease-patient-characteristics-and-outcomes/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley